These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2114020)
1. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets. Ciftçi K; Capan Y; Oztürk O; Hincal AA Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020 [TBL] [Abstract][Full Text] [Related]
2. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation. Emami J; Tavakoli N; Movahedian A J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014 [TBL] [Abstract][Full Text] [Related]
3. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets]. Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets. Effect of different diets on the bioavailability. Gai MN; Ferj S; García E; Seitz C; Thielemann AM; Andonaegui MT Drug Dev Ind Pharm; 1999 Feb; 25(2):131-40. PubMed ID: 10065346 [TBL] [Abstract][Full Text] [Related]
6. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation. Bulut-Oner F; Capan Y; Kas S; Oner L; Hincal AA Farmaco; 1989; 44(7-8):739-52. PubMed ID: 2590371 [TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of sustained-release tablets of lithium in a fat matrix and its bioavailability in humans. Llabrés M; Fariña JB J Pharm Sci; 1991 Nov; 80(11):1012-6. PubMed ID: 1815050 [TBL] [Abstract][Full Text] [Related]
8. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form. Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets. Guelen PJ; Janssen TJ; De Witte TC; Vree TB; Benson K Biopharm Drug Dispos; 1992 Oct; 13(7):503-11. PubMed ID: 1489941 [TBL] [Abstract][Full Text] [Related]
10. Absorption of lithium following administration of slow-release and conventional preparations. Tyrer S; Hullin RP; Birch NJ; Goodwin JC Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297 [TBL] [Abstract][Full Text] [Related]
11. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide. Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152 [TBL] [Abstract][Full Text] [Related]
12. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations. Arancibia A; Corvalan F; Mella F; Concha L Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949 [TBL] [Abstract][Full Text] [Related]
13. The effect of media and other variables on the BP solution rate test for slow lithium carbonate tablets. Wall BP; Parkin JE; Sunderland VB J Pharm Pharmacol; 1986 Sep; 38(9):633-7. PubMed ID: 2877060 [TBL] [Abstract][Full Text] [Related]
14. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [TBL] [Abstract][Full Text] [Related]